Litigation Details for Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc. (N.D.W. Va. 2015)
✉ Email this page to a colleague
Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc. (N.D.W. Va. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-06-26 |
| Court | District Court, N.D. West Virginia | Date Terminated | 2017-09-12 |
| Cause | 35:271 Patent Infringement | Assigned To | Irene Patricia Murphy Keeley |
| Jury Demand | None | Referred To | |
| Patents | 6,551,620; 8,337,886; 8,496,965; 8,865,688 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc. (N.D.W. Va. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-04-12 | 117 | These include: Patent No. 6,551,620 (“the ‘620 Patent”); Patent No. 8,337,886 (“…the ‘886 Patent”); Patent No. 8,496,965 (“the ‘965 Patent”); and 8,865,688 (“the ‘688 Patent”). The …CONSTRUING PATENT CLAIMS This patent infringement case involves four United States patents issued …‘620, ‘886, and ‘965 Patents, collectively referred to as the Otterbeck patents,1 contain two disputed…dispute one claim term in the ‘688 Patent. The Otterbeck patents cover a controlled | External link to document | |
| 2017-04-10 | 208 | Regarding Infringement of United States Patent Number 8,865,688 by Dr. Falk Pharma GmbH, Salix Pharmaceuticals… 12 September 2017 1:15-cv-00109 830 Patent None District Court, N.D. West Virginia | External link to document | |
| 2017-05-05 | 226 | Regarding Infringement of United States Patent Number 8,865,688 filed by Dr. Falk Pharma GmbH, Salix Pharmaceuticals… 12 September 2017 1:15-cv-00109 830 Patent None District Court, N.D. West Virginia | External link to document | |
| 2017-05-10 | 230 | Post-Trial Brief Regarding Infringement of U.S. Patent No. 8,865,688 Other Document filed by Dr. Falk Pharma … 12 September 2017 1:15-cv-00109 830 Patent None District Court, N.D. West Virginia | External link to document | |
| 2017-07-10 | 249 | infringement and invalidity of U.S. Patent No. 8,865,688 (“the ‘688 patent”) (Dkt. No. 238). Significantly…Plaintiffs alleging infringement of claim 2 of the 688 patent are DISMISSED WITH PREJUDICE; Except for the limited…respecting the invalidity of claim 1 of the 688 patent, and consistent with the provisions of paragraph…counterclaims of invalidity with respect to the688 patent are DISMISSED WITH PREJUDICE; Should the United…PTABs Determination regarding claim 1 of the 688 patent, or in the event there is no appeal from the PTABs | External link to document | |
| 2019-08-06 | 281 | Judgment - Consent | regarding the invalidity of Claim 1 of the U.S. Patent No. 8,865,688 in this matter, Plaintiffs Salix Pharmaceuticals…this action as follows: 1, Claim 1 of U.S. Patent No. 8,865,688 that has been asserted in this Civil Action… determination of the Patent Trial and Appeal Board of the United States Patent and Trademark Office regarding… 12 September 2017 1:15-cv-00109 830 Patent None District Court, N.D. West Virginia | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
